Aspirine OÜ

Active Registry code 16191858 OÜ Tallinn Registered 24 Mar 2021
Compare

Aspirine OÜ is a OÜ based in Tallinn, registry code 16191858, status: active. Main activity: Other human health activities n.e.c.. Its annual report for 2024 shows revenue of €0 and 0 employees.

Revenue
0 €
↓ 100.0% vs 2023
Employees
0
±0 vs 2023

2024 · annual report, e-Äriregister

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2024 0 €
    industry median 20 000 € · companies in the industry: 3 347

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2021 – 2024
Revenue, € 2024: 0 € · −100.0% vs 2023 · industry median 20 000 € · above 5% of the industry
010 00020 00030 0002021 Company: 29 685 € Industry median: 20 121 €20212022 Company: 0 € Industry median: 20 030 €20222023 Company: 5 814 € Industry median: 19 469 €20232024 Company: 0 € Industry median: 20 000 €2024010 00020 00030 0002021 Company: 29 685 € Industry median: 20 121 €2022 Company: 0 € Industry median: 20 030 €20222023 Company: 5 814 € Industry median: 19 469 €2024 Company: 0 € Industry median: 20 000 €2024
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2024: -18 € · −123.1% vs 2023 · industry median 1 621 € · above 25% of the industry
-1 00001 0002 0002021 Company: 891 € Industry median: 1 834 €20212022 Company: -936 € Industry median: 1 525 €20222023 Company: 78 € Industry median: 1 745 €20232024 Company: -18 € Industry median: 1 621 €2024-1 00001 0002 0002021 Company: 891 € Industry median: 1 834 €2022 Company: -936 € Industry median: 1 525 €20222023 Company: 78 € Industry median: 1 745 €2024 Company: -18 € Industry median: 1 621 €2024
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2023: 1.3 % · industry median 11.4 % · above 26% of the industry
0510152021 Company: 3.0 % Industry median: 13.0 %20212022 Company: — Industry median: 11.3 %20222023 Company: 1.3 % Industry median: 11.4 %20232024 Company: — Industry median: 10.7 %20240510152021 Company: 3.0 % Industry median: 13.0 %2022 Company: — Industry median: 11.3 %20222023 Company: 1.3 % Industry median: 11.4 %2024 Company: — Industry median: 10.7 %2024
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2024: 130 € · −11.6% vs 2023
02004006008001 0002021 Company: 937 €20212022 Company: 0 €20222023 Company: 147 €20232024 Company: 130 €202402004006008001 0002021 Company: 937 €2022 Company: 0 €20222023 Company: 147 €2024 Company: 130 €2024
Equity, € 2024: 17 € · −50.0% vs 2023
-20002004006008001 0002021 Company: 892 €20212022 Company: -45 €20222023 Company: 34 €20232024 Company: 17 €2024-20002004006008001 0002021 Company: 892 €2022 Company: -45 €20222023 Company: 34 €2024 Company: 17 €2024
Employees 2024: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02.52021 Company: 0 Industry median: 2.520212022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 220240.00.51.01.52.02.52021 Company: 0 Industry median: 2.52022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 22024 Company: 0 Industry median: 22024
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2024 0 -18 0 130 17 0
2023 5 814 78 — 147 34 0
2022 0 -936 — 0 -45 0
2021 29 685 891 — 937 892 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2024

Return on equity (ROE)
-105.9 %
Net profit / equity
Return on assets (ROA)
-13.8 %
Net profit / assets
Equity ratio
13.1 %
Equity / assets
Debt ratio
86.9 %
Liabilities / assets
Current ratio
1.15
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2024 1 Jan 2024 – 31 Dec 2024 27 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 2 Aug 2024 Company’s own e-Äriregister
2022 1 Jan 2022 – 31 Dec 2022 28 Jun 2023 Company’s own e-Äriregister
2021 24 Mar 2021 – 31 Dec 2021 28 Jun 2023 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 86909Other human health activities n.e.c. Main

Rulings 6

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50169896 / M3
17 Jul 2024
 Warning of deletion from the register: annual report not filed 20 Oct 2024 Deficiencies eliminated
3 Aug 2024
 PDF
Ä 50169896 / 3
2 Sep 2023
 Amendment entry In force
2 Sep 2023
 PDF
Ä 50169896 / M2
18 May 2023
 Ruling to be served In force
1 Jun 2023
 PDF
Ä 50169896 / M1
5 May 2023
 Procedural ruling 15 May 2023 In force
5 May 2023
 PDF
Ä 50169896 / 2
3 May 2023
 Amendment entry In force
3 May 2023
 PDF
Ä 50169896
24 Mar 2021
 First entry In force
24 Mar 2021
 PDF

Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data